Literature DB >> 184363

Effect of chronic administration of propranolol on lipoprotein composition.

N Tanaka, S Sakaguchi, K Oshige, T Niimura, T Kanehisa.   

Abstract

Chronic effects of propranolol on plasma lipids and lipoprotein composition were examined in ten patients who had previous strokes and normal plasma lipids. Although plasma triglyceride and total cholesterol were not affected by propranolol, a slight decrease of free cholesterol and phospholipids and a significant increase of free fatty acids were observed in the eighth week of propranolol treatment. Reciprocal changes were observed in lipoprotein composition; these were an increase in lipids of very low-density lipoprotein and a decrease in lipids of both low-density and high-density lipoproteins. Postheparin lipolytic activity was significantly suppressed by the administration of propranolol. Inhibition of lipoprotein lipase by propranolol was considered to have played a role in the reciprocal changes of lipoprotein composition.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 184363     DOI: 10.1016/0026-0495(76)90014-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  33 in total

1.  Beta-blockers and lipid metabolism.

Authors:  A Nilsson; B G Hansson; B Hökfelt
Journal:  Br Med J       Date:  1977-07-09

2.  Effect of propranolol on plasma concentrations of HDL apoprotein and lipid.

Authors:  P Hooper
Journal:  Br Med J       Date:  1979-01-20

3.  Failure of the nonselective beta-blocker propranolol to affect lipoprotein lipase gene expression in the rat.

Authors:  I Gouni-Berthold; K Oka; H K Berthold; L Chan
Journal:  Lipids       Date:  1997-09       Impact factor: 1.880

Review 4.  [Alterations of fat metabolism in renal disease - pathogenetic mechanisms (author's transl)].

Authors:  W H Hörl; M Hörl; A Heidland
Journal:  Klin Wochenschr       Date:  1982-04-01

Review 5.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

6.  Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects.

Authors:  S Rössner; L Weiner
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  [Antihypertensive therapy and lipid metabolism].

Authors:  W Krone; D Müller-Wieland; H Greten
Journal:  Klin Wochenschr       Date:  1984-03-01

8.  The effect of two beta-adrenoceptor blockers (mepindolol and atenolol) on blood lipids and platelet aggregation in normal volunteers and essential hypertensive patients.

Authors:  M Luque Otero; C Fernandez Pinilla; A Escriba Polo; M Rodriguez Vazquez; N Martell Claros; A Fernandez-Cruz
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

9.  Beta adrenoceptor blockade and responses of serum lipids to a meal and to exercise.

Authors:  N R Peden; R J Dow; T E Isles; B T Martin
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

10.  Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

Authors:  J L Day; N Simpson; J Metcalfe; R L Page
Journal:  Br Med J       Date:  1979-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.